ADHD – Medxy AI

ADHD and Risk of Late-Life Cognitive Impairment: Insights from Clinical and Genetic Data

By MedXY 10/13/2026

A comprehensive cohort study demonstrates that ADHD significantly increases the risk of mild cognitive impairment and dementia in older adults, highlighting the need for targeted monitoring and integrated care in this vulnerable population.

news Psychiatry

Evolving Genetic Contributions to ASD and ADHD: Insights from Diagnosis Trends (1994–2016)

By MedXY 09/24/2026

A Danish cohort study reveals decreased genetic risk profiles in recent ASD and ADHD diagnoses, supporting broader diagnostic criteria as a driver of rising incidence rates.

Clinical Updates news OB/GYN & Women's Health Psychiatry

Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence Review

By MedXY 09/09/2026

This review synthesizes current evidence on the impact of continuing psychostimulant treatment during pregnancy on postpartum mental health outcomes among people with ADHD, highlighting key findings and clinical implications from recent large-scale cohort research.

news OB/GYN & Women’s Health Pediatrics

Sibling-Controlled Evidence Reassures Safety of Prenatal Acetaminophen Use Regarding Autism and ADHD Risks

By MedXY 07/07/2026

A large sibling-matched cohort study found no link between prenatal acetaminophen exposure and autism or ADHD, suggesting prior associations were confounded by familial factors and supporting the safety of indicated paracetamol use during pregnancy.

news Psychiatry Public Health

Earlier ADHD Diagnosis May Mark a Better Educational Trajectory: What a Finnish Registry Study Found

By MedXY 06/15/2026

In a nationwide Finnish cohort, earlier ADHD diagnosis was linked to better school performance, more academic progression, and less dropout than diagnosis closer to age 16, especially before educational track selection.

Clinical Updates Neurology news Psychiatry

Mapping ADHD Heterogeneity: A New Frontier in Neurobiological Biotyping through Morphometric Similarity Networks

By MedXY 02/27/2026

This review explores a groundbreaking study using normative modeling and morphometric similarity networks to identify three distinct neurobiological biotypes of ADHD, providing a framework for precision psychiatry.

news Psychiatry Public Health

Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife

By MedXY 02/12/2026

A 46-year longitudinal study reveals that childhood ADHD traits significantly predict higher rates of physical health conditions, multimorbidity, and disability by middle age, mediated by modifiable risk factors like smoking, BMI, and psychological distress.

news Psychiatry

Prenatal Maternal Depression as a Critical Developmental Risk Factor: Large-Scale IPD Meta-Analysis of 76,514 Children

By MedXY 02/07/2026

This large-scale individual participant data meta-analysis of 76,514 children reveals that prenatal maternal depression is significantly associated with increased risks of ADHD, ASD, and behavioral symptoms, independent of pre-pregnancy depression and largely consistent across both male and female offspring.

news Psychiatry

Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes

By MedXY 01/25/2026

Recent large-scale cohort studies suggest that previously observed links between prenatal exposure to acid-suppressants or antipsychotics and neurodevelopmental disorders are largely due to familial confounding. Conversely, active maternal eating disorders remain a significant risk factor, highlighting the critical role of maternal health optimization.

news Pediatrics Psychiatry

Lifespan Management of ADHD: Landmark Umbrella Review Identifies Optimal Interventions and Critical Evidence Gaps

By MedXY 12/30/2025

A comprehensive BMJ umbrella review synthesizes evidence for ADHD interventions across the lifespan, confirming the efficacy of stimulants and non-stimulants in the short term while revealing a critical lack of high-certainty long-term data and introducing a new digital platform for shared clinical decision-making.

news Pediatrics Psychiatry

Methylphenidate for ADHD in Children and Adolescents: Modest Symptom Gains but Uncertain Net Benefit

By MedXY 12/16/2025

Updated Cochrane analysis (212 RCTs, 16,302 participants) finds methylphenidate may reduce teacher-rated ADHD symptoms and improve general behaviour but increases non‑serious adverse events; overall evidence certainty is very low.

news Pediatrics

Maternal Paracetamol in Pregnancy and Child Neurodevelopment: Current Evidence Does Not Establish a Clear Causal Link

By MedXY 11/22/2025

An umbrella review of systematic reviews finds low to critically low confidence in studies linking prenatal paracetamol exposure to autism or ADHD; sibling-controlled analyses largely attenuate associations. Clinical guidance: use lowest effective dose for clear indications and avoid unnecessary prolonged use.

news Psychiatry Public Health

Telehealth Prescribing of ADHD Stimulants: Assessing Risks for Subsequent Substance Use Disorders

By MedXY 10/30/2025

This study evaluates whether initiating ADHD stimulant prescriptions via telehealth affects later risks of stimulant or other substance use disorders, finding no SUD risk increase but a potential rise in stimulant use disorder risk.

news Pediatrics Psychiatry

Early Diagnosis and Treatment Patterns of ADHD in Preschool Children: Insights from a National Electronic Health Record Study

By MedXY 10/27/2025

This study analyzes the diagnosis and medication initiation of ADHD among children aged 3-5 across multiple US health systems, highlighting sociodemographic disparities and clinical practices.

news Psychiatry Public Health

Rising Trends in Stimulant Use Disorder Diagnoses Among Adolescent and Young Adult Medicaid Enrollees: Implications for Clinical Practice

By MedXY 10/15/2025

Stimulant use disorder diagnoses in young adult Medicaid enrollees have markedly increased from 2001 to 2020, especially for noncocaine psychostimulants, highlighting an urgent need for targeted interventions and evidence-based treatments amid rising overdose risks.

Neurology Pediatrics Psychiatry Specialties

Unraveling ADHD: Gut Microbial Signatures and the Role of SCFA Deficiency in Symptom Pathogenesis

By MedXY 09/29/2025

Recent research reveals distinct gut microbial and metabolic profiles linked to ADHD symptoms, highlighting short-chain fatty acid deficiency as a key mechanism driving hyperactivity and inattention.

Medical News Neurology news Pediatrics Psychiatry Specialties

ADHD Drugmakers Double Marketing Spending to Clinicians: Implications for Prescribing and Patient Care

By MedXY 09/01/2025

Pharmaceutical companies have significantly increased marketing payments to clinicians for ADHD medications, particularly targeting advanced practice clinicians. The impact of this trend on prescribing patterns and clinical benefits remains to be fully understood.

Family Medicine & Nutrition news Pediatrics Specialties

Micronutrient Supplementation Modulates Gut Microbiome in Children with ADHD: Insights from the MADDY Study

By MedXY 08/27/2025

The MADDY study reveals that micronutrient supplementation in children with ADHD alters gut microbial diversity and composition, notably increasing beneficial butyrate-producing bacteria, potentially underpinning improved behavioral outcomes.

Clinical Updates Neurology news Pediatrics Specialties Superintelligence

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation

By MedXY 08/24/2025

A tailored, app-supported exercise program delivered via mobile health significantly improves core ADHD symptoms and executive functions in children, demonstrating comparable effectiveness to traditional face-to-face exercise guidance.

Allergy & Immunology Clinical Updates Neurology news Psychiatry Respiratory Specialties

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD

By MedXY 08/04/2025

A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.